Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Decrease in Angiotensin-Converting Enzyme activity but not concentration in plasma/lungs in COVID-19 patients offers clues for diagnosis/treatment
Henry Daniell, Smruti K. Nair, Yao Shi, et al.
Molecular Therapy — Methods & Clinical Development (2022) Vol. 26, pp. 266-278
Open Access | Times Cited: 21

Showing 21 citing articles:

Autoantibodies to ACE2 and immune molecules are associated with COVID-19 disease severity
Eric S. Geanes, Rebecca McLennan, Cas LeMaster, et al.
Communications Medicine (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 10
Renin-Angiotensin System and Sex Differences in COVID-19: A Critical Assessment
Mark C. Chappell
Circulation Research (2023) Vol. 132, Iss. 10, pp. 1320-1337
Open Access | Times Cited: 17
S Protein, ACE2 and Host Cell Proteases in SARS-CoV-2 Cell Entry and Infectivity; Is Soluble ACE2 a Two Blade Sword? A Narrative Review
Reza Nejat, Maziar Fayaz Torshizi, David J. Najafi
Vaccines (2023) Vol. 11, Iss. 2, pp. 204-204
Open Access | Times Cited: 15
Clinical studies in Myxomatous Mitral Valve Disease dogs: most prescribed ACEI inhibits ACE2 enzyme activity and ARB increases AngII pool in plasma
Smruti K. Nair, Henry Daniell, Elliot V. Hersh, et al.
Hypertension Research (2025)
Open Access
Immune system-related soluble mediators and COVID-19: basic mechanisms and clinical perspectives
Mohammad Sadegh Soltani‐Zangbar, Forough Parhizkar, Mojtaba Abdollahi, et al.
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 21
The Renin–Angiotensin System (RAS) in COVID-19 Disease: Where We Are 3 Years after the Beginning of the Pandemic
Marco Prato, Natalia Tiberti, Cristina Mazzi, et al.
Microorganisms (2024) Vol. 12, Iss. 3, pp. 583-583
Open Access | Times Cited: 3
Ursodeoxycholic acid does not reduce SARS-CoV-2 infection in newly allogeneic hematopoietic stem cell transplantation recipients: a prospective NICHE cohort
Hongye Gao, Jiali Wang, Xinhui Zheng, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 2
Low Ang-(1–7) and high des-Arg9 bradykinin serum levels are correlated with cardiovascular risk factors in patients with COVID-19
Farzaneh Rostamzadeh, Hamid Najafipour, Samira Nakhaei, et al.
Open Medicine (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 4
Serum angiotensin-converting enzyme 2 as a potential biomarker for SARS-CoV-2 infection and vaccine efficacy
Matthew P. Lennol, María‐Salud García‐Ayllón, Mariano Estéban, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 6
Mechanism Underlying the Immune Responses of a Sublingual Vaccine for SARS-CoV-2 with RBD Antigen and Adjuvant, Poly(I:C) or AddaS03, in Non-human Primates
Tetsuro Yamamoto, Fusako Mitsunaga, Kunihiko Wasaki, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
The Serum ACE2, CTSL, AngII, and TNFα Levels after COVID-19 and mRNA Vaccines: The Molecular Basis
Mina Pencheva, Martina Bozhkova, Yordan Kalchev, et al.
Biomedicines (2023) Vol. 11, Iss. 12, pp. 3160-3160
Open Access | Times Cited: 2
Extracellular vesicles and angiotensin-converting enzyme 2 in COVID-19 disease
Yu Liu, ROBERT J. KASPER, NATALIE J. S. CHOI
Biocell (2024) Vol. 48, Iss. 1, pp. 1-8
Open Access
Modulation of the pharmacokinetics of soluble ACE2 decoy receptors through glycosylation
Savanna S. Skeeters, Kamal Bagale, Galina A. Stepanyuk, et al.
Molecular Therapy — Methods & Clinical Development (2024) Vol. 32, Iss. 3, pp. 101301-101301
Closed Access
Reduced Salivary Gustin and Statherin in Long-COVID Cohort with Impaired Bitter Taste
H. Chowdary, Naomi Riley, Parul Patel, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 22, pp. 6816-6816
Open Access
Evaluation of Biologics ACE2/Ang(1–7) Encapsulated in Plant Cells for FDA Approval: Safety and Toxicology Studies
Henry Daniell, Geetanjali Wakade, Smruti K. Nair, et al.
Pharmaceutics (2024) Vol. 17, Iss. 1, pp. 12-12
Open Access
ACE2 Receptor: A Potential Pharmacological Target in COVID-19
Yaping Zhu, Shungeng Zhang, Zeguang Wang, et al.
Current Protein and Peptide Science (2023) Vol. 24, Iss. 9, pp. 701-710
Closed Access | Times Cited: 1
Circulating angiotensin converting enzyme 2 and COVID-19
Wattana Leowattana, Tawithep Leowattana, Pathomthep Leowattana
World Journal of Clinical Cases (2022) Vol. 10, Iss. 34, pp. 12470-12483
Open Access | Times Cited: 2
S protein, ACE2 and Host Cell Proteases in SARS-CoV2 Cell Entry and Infectivity; Is Soluble ACE2 a Two Blade Sword?
Reza Nejat, Maziar Fayaz Torshizi, David J. Najafi
(2022)
Open Access | Times Cited: 1
The Emerging Role of Photobiomodulation in COVID-19 Therapy – Part I
Richard Williams
Medical Research Archives (2023) Vol. 11, Iss. 8
Open Access
Levels of Angiotensin and Kinin Metabolite Peptides Related to COVID-19 Severity
Ben K. Ahiadu, Ami Grunbaum, Nicholas Rozza, et al.
ACS Pharmacology & Translational Science (2023)
Closed Access
Bioinformatics and systems biology approaches to identify the effects of COVID-19 on neurodegenerative diseases: A review
Fan Bu, Ruiqian Guan, Wanyu Wang, et al.
Medicine (2022) Vol. 101, Iss. 49, pp. e32100-e32100
Open Access
Page 1

Scroll to top